The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Nobivac DHPPi

Intervet Ireland LimitedVPA10996/166/001

Main Information

Trade NameNobivac DHPPi
Active SubstancesCanine distemper virus strain ondertespoort (live)
Canine adenovirus type 2 strain manhattan lpv3 (live)
Canine parvovirus strain 154 (live)
Canine parainfluenza virus strain Cornell (Live)
Dosage FormLyophilisate for solution for injection
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/166/001

Group Information

ATC CodeQI07AD04 canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus
Therapeutic ClassImmunological - Live Vaccine


License statusAuthorised
Licence Issued03/06/2005
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back